An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization

Cell
|December 1, 1978
PubMed

Insights

Researchers identified a Rous sarcoma virus mutant (SE 21Q1b) that fails to package its own RNA, instead packaging cellular RNA. This RNA packaging defect prevents viral replication and transformation, highlighting a critical step in retroviral assembly.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • Avian retroviruses, such as Prague Rous Sarcoma Virus (PR-RSV-E), are crucial tools for studying cell transformation and viral replication.
  • Viral RNA packaging is a complex process essential for the assembly of infectious virions.
  • Understanding mutations affecting RNA packaging can elucidate the mechanisms of retroviral assembly and host-cell interactions.

Purpose of the Study:

  • To characterize a novel nonconditional mutant of PR-RSV-E, designated SE 21Q1b, with distinct properties related to viral particle formation.
  • To investigate the molecular basis for the observed defect in RNA packaging and its impact on viral infectivity.
  • To explore the consequences of this packaging defect on viral gene expression and the potential for genetic rescue.

Main Methods:

  • Isolation and continuous culture of a PR-RSV-E mutant (SE 21Q1b) from transformed quail cells.
  • Analysis of viral particle composition, including RNA content and protein components.
  • Infectivity assays to assess the transformation and replication potential of SE 21Q1b virions.
  • Superinfection experiments with other retroviruses to evaluate genetic rescue and packaging interference.

Main Results:

  • SE 21Q1b virions are produced by continuously growing transformed quail cells but are unable to infect or replicate in other cells.
  • These virions contain cellular RNAs and 4S RNA instead of the genomic 39S RNA, indicating a failure in specific viral RNA packaging.
  • Viral proteins and RNA-dependent DNA polymerase within SE 21Q1b virions are functional, and viral RNAs are synthesized and translated in producer cells.
  • Superinfection allows packaging of superinfecting viral RNA but does not rescue SE 21Q1b genetic markers or correct the aberrant cellular RNA packaging.

Conclusions:

  • SE 21Q1b represents an RNA packaging mutant of PR-RSV-E, characterized by the preferential packaging of cellular RNAs over viral genomic RNA.
  • The mutation likely involves a defect in a signal required for efficient genomic RNA packaging or an altered packaging factor with changed specificity.
  • This mutant provides a valuable model for studying the mechanisms of retroviral RNA selection and packaging, and the interplay between viral and cellular RNAs.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...